Implication of extended lymph node dissection stratified for advanced gastric cancer

Anticancer Res. 2003 Sep-Oct;23(5b):4181-6.

Abstract

Background: What extent of lymph node dissection for advanced gastric cancer is appropriate is a matter of controversy.

Patients and methods: Three hundred and ninety-nine gastric cancer patients underwent potentially curative D2 gastrectomy and 125 underwent D3 gastrectomy between 1985 and 1998.

Results: Our study revealed that pN3, but not D3 gastrectomy, significantly influenced prognosis. There was no significant difference in the 5-year survival rate and mean survival time between D2 and D3 patients: but the survival in D3 patients with tumor diameters measuring 50-100 mm or with pN1 was significantly longer than that in D2 patients with the same tumors. Analysis of survival of patients with tumor diameters measuring 50-100 mm revealed that there was a significant difference only in pN1. The incidence of lymphatic recurrence was significantly lower in D3 patients with pN1 tumor or a tumor measuring 50-100 mm than in D2 patients.

Conclusion: Patients with advanced gastric cancer measuring 50-100 mm and pN1 may benefit from para-aortic lymph node dissection.

MeSH terms

  • Female
  • Follow-Up Studies
  • Gastrectomy / adverse effects
  • Humans
  • Lymph Node Excision
  • Lymph Nodes / pathology
  • Lymph Nodes / surgery*
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Morbidity
  • Neoplasm Recurrence, Local / pathology
  • Prognosis
  • Retrospective Studies
  • Stomach Neoplasms / surgery*
  • Survival Rate